$CMRX CHIMERIX INC Insider Trading
Get free email notifications about insider trading in CHIMERIX INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CHIMERIX INC. Insider overview, share value development, latest insider transactions and email notifications about new events in CHIMERIX INC for free.
IRS Number: 330903395
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CMRX
Company Address: 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM 27713
Phone number: 919.806.1074
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.
Market Capitalization: $255.66M
Prev close: $5.50
Average Daily Volume: 520,534
Days Low: $5.35
Year Low: $3.49
Year High: $7.97
CHIMERIX INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2021 | CMRX | CHIMERIX INC | Vakiener Victoria | Director | Option Exercise | A | 7.84 | 35,000 | 274,400 | 35,000 | |
| Jun 25 2021 | CMRX | CHIMERIX INC | Gilliss Catherine | Director | Option Exercise | A | 7.84 | 35,000 | 274,400 | 35,000 | |
| Apr 26 2021 | CMRX | CHIMERIX INC | Vakiener Victoria | Director | Option Exercise | A | 8.22 | 60,000 | 493,200 | 60,000 | |
| Apr 07 2021 | CMRX | CHIMERIX INC | Jakeman David | Principal Accountin ... | Option Exercise | M | 2.35 | 5,250 | 12,338 | 0 | |
| Apr 07 2021 | CMRX | CHIMERIX INC | Jakeman David | Principal Accountin ... | Option Exercise | M | 2.35 | 5,250 | 12,338 | 0 | |
| Apr 07 2021 | CMRX | CHIMERIX INC | Jakeman David | Principal Accountin ... | Sell | S | 9.68 | 1,284 | 12,427 | 102,705 | 104 K to 102.7 K (-1.23 %) |
| Apr 07 2021 | CMRX | CHIMERIX INC | Jakeman David | Principal Accountin ... | Sell | S | 9.68 | 1,284 | 12,427 | 102,705 | 104 K to 102.7 K (-1.23 %) |
| Apr 07 2021 | CMRX | CHIMERIX INC | Jakeman David | Principal Accountin ... | Buy | M | 2.35 | 5,250 | 12,338 | 103,989 | 98.7 K to 104 K (+5.32 %) |
| Apr 07 2021 | CMRX | CHIMERIX INC | Jakeman David | Principal Accountin ... | Buy | M | 2.35 | 5,250 | 12,338 | 103,989 | 98.7 K to 104 K (+5.32 %) |
| Mar 01 2021 | CMRX | CHIMERIX INC | Meyer Robert J. | Director | Buy | P | 9.80 | 1,500 | 14,700 | 15,000 | 13.5 K to 15 K (+11.11 %) |
| Jan 29 2021 | CMRX | CHIMERIX INC | Jakeman David | Principal Accountin ... | Sell | S | 8.61 | 3,211 | 27,650 | 96,906 | 100.1 K to 96.9 K (-3.21 %) |
| Jan 26 2021 | CMRX | CHIMERIX INC | Sherman Michael A. | Chief Executive Off ... | Option Exercise | A | 9.28 | 700,000 | 6,496,000 | 700,000 | |
| Jan 26 2021 | CMRX | CHIMERIX INC | Melemed Allen S. | Chief Medical Offic ... | Option Exercise | A | 9.28 | 190,000 | 1,763,200 | 190,000 | |
| Jan 26 2021 | CMRX | CHIMERIX INC | Jakeman David | Principal Accountin ... | Option Exercise | A | 9.28 | 30,000 | 278,400 | 30,000 | |
| Jan 26 2021 | CMRX | CHIMERIX INC | Jakeman David | Principal Accountin ... | Grant | A | 0.00 | 15,000 | 0 | 100,117 | 85.1 K to 100.1 K (+17.62 %) |